2024 Active Requests for Applications (RFA's) | |
RFA No. and Title | Status - Expiration |
---|---|
CA24-014 Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P50 Clinical Trial Optional) | ACTIVE - OCT 02, 2024 |
2023 Active Program Announcements (PAs) | |
PA No. and Title | Status - Expiration |
---|---|
PAR23-284 Specialized Programs of Research Excellence (SPOREs) in Human Cancers for Years 2024, 2025, and 2026 (P50 Clinical Trial Required) | ACTIVE - SEP 26, 2026 |